Veru logo

Veru

VERU | NASDAQ
Chart Builder DCF Calculator
$2.08
-$0.01 (-0.48%)
At close: Nov 16, 2026, 4:00 PM ET
$2.10
+$0.02 (+0.96%)
After-hours: Nov 16, 2026, 7:52 PM ET
-0.48%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
25.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #913/1021 (Top 89%)

Key Statistics

Market Data

Market Cap $47.94M
1D Range
2.03 2.14
52W Range
2.03 4.23

Valuation (TTM)

PE -3.47
PB 1.69
EV/EBITDA -0.99

Valuation (NTM)

Forward PE N/A
Forward PEG -1.20
Price Target $4.00
Loading financial charts...

Profile

Veru Inc. operates as a biopharmaceutical firm primarily dedicated to advancing novel therapeutic agents for various types of cancer. Commercially, Veru markets the FC2 internal condom, designed to of...

Sector Healthcare
Industry Biotechnology
Employees 20
IPO Date Feb 11, 1999
Fiscal Year October - September

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$4.00
Upside
+92.31%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.